GlassScriptPhysician profile
Wendell K Ellis
NPI 1093875973
$4,331.04
in general payments reported to CMS, 2019-2025
29 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $334 · 2021: $601 · 2022: $564 · 2023: $657 · 2024: $453 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348 · Education: $32.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.10 |
| Education | $32.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $481.61 | 2019-2024 | Xarelto |
| Pfizer INC. | $459.02 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $458.67 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $410.46 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $276.99 | 2023-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $265.56 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $257.53 | 2021-2025 | Esprit, Diamondback Peripheral |
| Amgen INC. | $255.27 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $216.78 | 2025 | Watchman Flx, General - Pain Management, Jetstream Sc |
| Shockwave Medical, INC | $149.81 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.80 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $121.03 | 2022 | |
| Abiomed | $119.46 | 2025 | |
| Alnylam Pharmaceuticals INC. | $110.38 | 2023-2025 | Amvuttra, Onpattro |
| Inspire Medical Systems, INC. | $92.76 | 2025 | Inspire |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $81.15 | 2019-2021 | |
| Esperion Therapeutics, INC. | $54.62 | 2024-2025 | Nexletol |
| Medtronic, INC. | $54.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.49 | 2021-2025 | |
| Edwards Lifesciences Corporation | $47.61 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $39.19 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $34.46 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.26 | 2019 | |
| Philips North America LLC | $27.46 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $27.14 | 2020-2021 | |
| Scpharmaceuticals INC. | $21.36 | 2023 | |
| Cvrx, INC. | $17.88 | 2025 | Barostim Neo System |
| Cardinal Health 200 LLC | $17.79 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendell Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.